Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHAIRMAN & CEO Patel Sanj K exercised 508,339 units of Class A Ordinary Share at a strike of $13.45 and sold $26,415,228 worth of Class A Ordinary Share (508,339 units at $51.96) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.